期刊文献+

FLG基因与特应性皮炎 被引量:6

Filaggrin Gene and Atopic Dermatitis
原文传递
导出
摘要 特应性皮炎是一种慢性、复发性、炎症性皮肤病,以皮肤干燥和剧烈瘙痒为特征。特应性皮炎的发病被认为与表皮通透屏障功能缺陷及免疫失调相关,目前争论的焦点在于哪一个作为其发病的始动因素。FLG基因对维持皮肤屏障功能的角质层的形成和水合起关键作用,FLG基因的失功能性突变可能是影响特应性皮炎临床表现型和病情严重性的重要因素,但特应性皮炎患者中由于FLG基因突变引起的特征目前尚未确定,提示FLG基因的失功能性突变可能并非特应性皮炎的特异性突变。 Atopic dermatitis is a chronic, recurrent, inflammatory disease of the skin characterized by xerotic skin and severe itching. The pathogenesis of atopic dermatitis is considered to be related to the epidermal permeability barrier defects and immuine disorders. The current debate is that which one as the onset of the initial factor, FLG gene is critical to the formation and hydration of the stratum corneum responsible for the barrier function of the skin. FLG gene loss-of-function mutations, may be important factors that affect the clinical phenotype and the severity of atopic dermatitis . The characteristics of atopic dermatitis patients due to the FLG gene mutations are not yet to be determined,indicating that the FLG gene loss-of -function mutations may not the specific mutations of atopic dermatitis.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2014年第5期521-523,共3页 The Chinese Journal of Dermatovenereology
基金 广东省科技计划项目(00114340130835045)
关键词 丝聚蛋白基因 丝聚蛋白 特应性 皮炎 FLG gene Filaggrin Atopic, dermatitis
  • 相关文献

参考文献3

二级参考文献57

  • 1张慧,杨森,张学军.特应性皮炎易感基因研究进展[J].国际遗传学杂志,2006,29(6):472-475. 被引量:3
  • 2Akdis CA, Akdis M, Bieber T, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/ PRACTALL Consensus Report. J Allergy Clin Immunol, 2006, 118( 1 ): 152-69.
  • 3Segre JA. Epidermal barrier formation and recovery in skin disorders. J Clin Invest, 2006, 116(5 ): 1150-1158.
  • 4Rawlings AV, Harding CR. Moisturization and skin barrier function. Derrnatol Ther, 2004, 17(Suppl 1 ): 43-48.
  • 5Sugarman JL, Fluhr JW, Fowler A J, et al. The objective severity assessment of atopic dermatitis score: an objective measure using permeability barrier function and stratum comeum hydration with computerassisted estimates for extent of disease. Arch Dermatol, 2003, 139(11 ): 1417-1422.
  • 6Kim DW, Park JY, Na GY, et al. Correlation of clinical features and skin barrier function in adolescent and adult patients with atopic dermatitis. Int J Dermatol, 2006, 45(6): 698-701.
  • 7Lee CH, Chuang HY, Shih CC, et al. Transepidermal water loss, serum IgE and beta -endorphin as important and independent biological markers for development of iteh intensity in atopie dermatitis. Br J Dermatol, 2006, 154(6): 1100-1107.
  • 8Aioi A, Tonogaito H, Suto H, et al. Impairment of skin barrier fimction in NC/Nga Tnd mice as a possible model for atopic dermatitis. Br J Dermatol, 2001, 144( 1 ): 12-18.
  • 9Ginger RS, Blachford S, Rowland J, et al. Filaggrin repeat number polymorphism is associated with a dry skin phenotype. Arch Dermatol Res, 2005, 297(6): 235-241.
  • 10Hudson TJ. Skin barrier function and allergic risk. Nat Genet, 2006, 38(4): 399-400.

共引文献19

同被引文献54

  • 1罗莉.徐长卿淀粉浴治疗老年性皮肤瘙痒症44例临床观察[J].中医药导报,2007,13(4):43-44. 被引量:4
  • 2Heo JC, Son HU, Kim SL, et al. A derivative of L-allo threonine alleviates 2, 4-dinitrofluorobenzene-induced atopic dermatitis indications [J]. Biosci Biotechnol Biochem, 2012, 76(11) : 2021-2025.
  • 3Eyerich K, Novak N. Immunology of atopic eczema: overcoming the Thl/Th2 paradigm [J]. Allergy, 2013, 68 (8) : 974-982.
  • 4De Benedetto A, Kubo A, Beck LA. Skin barrier disruption: a requirement for allergen sensitization&quest [J]. J Invest Dermatol, 2012, 132(3 pt 2) : 949-963.
  • 5Miyagaki T, Sugaya M. Recent advances in atopie dermatitis and psoriasis : Genetic background, barrier function, and therapeutic targets [J]. J Dermatol Sei, 2015,78(2):89-94.
  • 6Pyun BY. Natural history and risk factors of atopic dermatitis in children [J]. Allergy Asthma Immunol Res, 2015, 7(2): 101-105.
  • 7Schneider L, Tilles S, Lio P, et al. Atopic dermatitis: a practice parameter update 2012 [J]. J Allergy Clin Immun, 2013, 131(2): 295-299.
  • 8Sybilski A J, Raciborski F, atopic dermatitis in Poland Allergic Disorders in Poland 2014, 42(2) : 140-147.
  • 9Lipiec A, et al. Epidemiology of according to the Epidemiology of (ECAP) study [J]. J Dermatol, Ring J, Alomar A, Bieber T, et al. Guidelines for treatment of atopic eczema (atopic dermatitis) Part II [J]. J Eur Acad Dermatol, 2012, 26(9): 1176-1193.
  • 10Weber TM, Herndon JH Jr, Ewer M , et al. Efficacy and tolerability of steroid-free, over-the-counter treatment formulations in infants and children with atopic dermatitis [J]. J Dermatol Nurses Assoc, 2015, 7(1):17-24.

引证文献6

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部